Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
NCT06631638

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

Led by DePuy Orthopaedics · Updated on 2026-05-08

118

Participants Needed

5

Research Sites

114 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this research is to gather clinical and radiographic (X-ray) information about EMPHASYS™ acetabular shell (also called a hip 'cup') placement in total hip replacement surgery using a non-invasive surgical navigation system called VELYS™ hip navigation system with CUPTIMIZE™ Advanced Hip-Spine Analysis software. Data collected in this study will be compared with data collected from implantations using different cup positioning instrumentation and techniques to assess performance.

CONDITIONS

Official Title

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • All hip replacement devices must be used according to approved indications
  • Undergoing standard primary uncemented hip replacement with EMPHASYS cup and CORAIL, EMPHASYS, or ACTIS stem via posterolateral, anterolateral, or direct lateral approach with lateral decubitus position
  • Candidate for implantation using VELYS Hip Navigation system with CUPTIMIZE Advanced Hip-Spine Analysis
  • Able to speak, read, and understand consent document and willing to provide consent
  • Willing and able to complete study follow-up as specified
  • Willing and able to complete Subject Hip Outcomes questionnaires (FJS-12, EQ-5D-5L, Hip Evaluation)
  • Not bedridden as determined by investigator
  • Minimum age of 21 years at time of consent
Not Eligible

You will not qualify if you...

  • Active local or systemic infection
  • Loss of musculature, neuromuscular issues, or vascular problems in affected limb making surgery unjustified
  • Poor bone quality such as osteoporosis risking prosthesis migration or fracture
  • Charcot's or Paget's disease
  • Pregnant or lactating women
  • Previous contralateral amputation
  • Previous partial hip replacement in affected hip
  • Participation in another clinical trial with investigational product in last 3 months
  • Contralateral hip replacement less than 6 months before surgery
  • Involvement in personal injury litigation or worker's compensation claims
  • Diagnosed muscular disorder treated with prescription medications limiting mobility due to stiffness and pain
  • Medical condition with less than 2 years life expectancy
  • Drug or alcohol abuse or psychological disorder affecting compliance or questionnaire completion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

UC Davis Health System

Sacramento, California, United States, 95817

Not Yet Recruiting

2

Florida Orthopaedic Institute

Gainesville, Florida, United States, 32607

Actively Recruiting

3

Northwell Health

Lake Success, New York, United States, 11042

Not Yet Recruiting

4

Montefiore Medical Center

The Bronx, New York, United States, 10461

Not Yet Recruiting

5

Carolina Orthopaedic and Sports Medicine Center

Gastonia, North Carolina, United States, 28054

Actively Recruiting

Loading map...

Research Team

S

Samantha Flamand

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here